Filing Flows › Guardant Health (GH) › Screening revenue
Guardant Health (GH) Screening revenue by quarter
Guardant Health's Screening revenue was $67.6M in Q3 2026 (third quarter 2026), +28% from Q2 2026. Over the last 7 quarters it ranged from $5.7M (Q1 2025) to $67.6M (Q3 2026).
| Quarter | Screening revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $67.6M | +28% | +180% |
| Q2 2026 | $52.9M | +27% | +257% |
| Q1 2026 | $41.6M | +18% | +633% |
| Q4 2025 | $35.1M | +46% | — |
| Q3 2025 | $24.1M | +63% | — |
| Q2 2025 | $14.8M | +161% | — |
| Q1 2025 | $5.7M | — | — |
Q3 2026 at a glance
Guardant Health, Q3 2026: revenue $361M (+36% year over year), operating margin -36.8%, net loss $124M, operating cash flow −$23.7M. The chart follows the revenue to costs, profit and cash.
Questions
What is Guardant Health's Screening revenue?
Guardant Health's Screening revenue was $67.6M in Q3 2026 (third quarter 2026), +28% from Q2 2026.
How has Guardant Health's Screening revenue changed?
Over the last 7 quarters it ranged from $5.7M (Q1 2025) to $67.6M (Q3 2026).